U.S. Markets open in 1 hr 49 mins

Amgen Inc. (AMGN)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
171.39+1.35 (+0.79%)
At close: 4:00PM EDT
People also watch
Full screen
Previous Close170.04
Bid168.90 x 200
Ask173.30 x 200
Day's Range170.14 - 172.63
52 Week Range133.64 - 184.21
Avg. Volume3,162,356
Market Cap125.06B
PE Ratio (TTM)16.28
Earnings DateN/A
Dividend & Yield4.60 (2.68%)
Ex-Dividend Date2017-08-15
1y Target EstN/A
Trade prices are not sourced from all markets
  • Market Realist5 minutes ago

    How Amgen’s Nephrology Drugs Are Positioned after 2Q17?

    In 2Q17, Amgen’s (AMGN) Aranesp generated revenues of ~$535 million, which represented a 6% year-over-year rise.

  • Market Realist21 hours ago

    What We May See from Amgen’s Vectibix in 2017

    In 2Q17, Amgen’s (AMGN) Vectibix generated revenues of ~$168 million, which represented a ~5% YoY (year-over-year) rise and a ~14% QoQ (quarter-over-quarter) rise. In the US, Vectibix generated revenues ...

  • Barrons.com22 hours ago

    Biogen: Goldman Has Conviction!

    Biogen (BIIB) has had a good, though not great year. Is it time to add it to your portfolio? Shares of Biogen have gained 11.5% so far this year, and while that's better than the S&P 500's 10.3% rise during ...